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A B S T R A C T
Enterococcus faecium is a commensal but also a bacteremia causing pathogen, which is inherently resistant to
several antimicrobials and has a great ability to acquire new traits. Bacterial membrane vesicles (MVs) are
increasingly recognized as a mode of cell-free communication and a way to deliver virulence factors and/or
antimicrobial resistance determinants. These features make MVs interesting research targets in research on
critical hospital pathogens. This study describes for the first time that E. faecium strains produce MVs. It presents
a morphological as well as a proteomic analysis of MVs isolated from four different, clinically relevant E. faecium
strains grown under two different conditions and identifies MV-associated proteins in all of them. Interestingly,
11 virulence factors are found among the MV-associated proteins, including biofilm-promoting proteins and
extracellular matrix-binding proteins, which may aid in enterococcal colonization. Additionally, 11 anti-
microbial resistance-related proteins were MV-associated. Among those, all proteins encoded by the vanA-cluster
of a vancomycin resistant strain were found to be MV-associated. This implies that E. faecium MVs may be
utilized by the bacterium to release proteins promoting virulence, pathogenicity and antimicrobial resistance.
Significance: Enterococcal infections, especially bacteremia and endocarditis, are challenging to treat because E.
faecium have acquired resistance to multiple classes of antimicrobials, including ampicillin, aminoglycosides,
and glycopeptides. Thus, research on different modes of enterococcal pathogenicity is warranted. This study
utilized a proteomic approach to identify MV-associated proteins of different nosocomial E. faecium strains re-
presenting four clinically relevant sequence types (STs), namely ST17, ST18, ST78, and ST192. The presented
data suggest that E. faecium MVs are involved in virulence and antimicrobial resistance.
1. Introduction
Enterococci are Gram-positive, ubiquitous, facultative anaerobic
cocci. They are known to survive hostile conditions such as a saline
environment and wide temperature ranges and also for their ability to
persist long-term in the hospital environment [1]. Enterococcus faecalis
and Enterococcus faecium naturally colonize the human gut as com-
mensals. However, E. faecium in particular has undergone a pronounced
transition towards a multi-drug resistant pathogen. The most common
infection caused by E. faecium is urinary tract infection, but they may
also cause life-threatening infections such as endocarditis and bacter-
emia, especially in debilitated patients [2]. The genetic clade structure
of E. faecium is characterized by a distinct split of commensal lineage
(clade B) and hospital-associated lineage (clade A1) [3]. The nosoco-
mial A1 clade includes sequence types (STs) of the clonal complex 17
(CC17), a globally spread genetic complex characterized by ampicillin
resistance, possession of a pathogenicity island and association with
hospital outbreaks [4].
Extracellular vesicles are suggested as a mechanism for cell-free
intercellular communication across all domains of life. They are crucial
components of the bacterial secretome, as these 20–200 nm sized
spheres contain lipopolysaccharides, soluble membrane-associated
proteins, virulence factors and nucleic acids [5, 6].
Bacterial membrane vesicles were first described in the Gram-
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negative Escherichia coli in the 1960s [7, 8], and later in several other
Gram-negative species such as Shigella sp. [9], Salmonella sp. [10], and
Vibrio sp. [11]. In Gram-negative bacteria, the vesicles are called outer-
membrane vesicles (OMVs), as they derive from the outer membrane
(OM). The OMVs contain OM components as well as inner membrane
constituents and cytoplasmic elements. The role of OMVs in bacterial
physiology and pathogenesis, stress responses, biofilm formation as
well as secretion and delivery of biomolecules has been demonstrated
[12]. The mechanism of vesiculogenesis is poorly understood but seems
to involve phospholipid accumulation in the outer leaflet of the outer
membrane, whereupon vesicles pinch off from the outer membrane
among Gram-negative bacteria [13].
It used to be a long-standing assumption that the thick cell wall of
Gram-positive bacteria precluded the existence of vesicles, as they
could not escape such a barrier. Gram-positive MVs were discovered in
a study from the early 1990s in Bacillus cereus and Bacillus subtilis [14],
but not further characterized for the next 20 years. Finally, in 2009 MVs
were described in Staphylococcus aureus [15] and have since gained
increased attention, i.e. in Bacillus anthracis [16], Mycobacterium tu-
berculosis [17] and others, as reviewed by Brown et al. [6]. MVs are key
players in host-pathogen interactions, as they can cause disease without
the living bacterial cell [18] and may induce strong host responses [19].
MV production in enterococci has not been described previously.
The aim of this study was therefore to explore the potential of MVs
release from E. faecium. In addition, we investigated whether different
cultural conditions and strain backgrounds may account for variation in
proteinaceous cargo. Four strains representing different, clinically im-
portant sequence types (STs) within CC17, the major disease causing
clonal complex [20]: ST17, ST18, ST78, and ST192 respectively, were
therefore chosen for the study. To the best of our knowledge, this is the
first report describing MV release by clinical strains of enterococci and
their proteomics-based characterization using an in-solution approach.
2. Materials and methods
2.1. Strains and growth conditions
In the present study, the E. faecium strains DO (PRJNA71), E155
(PRJNA192879), K59-68 (in-house sequenced, under submission) and
K60-39 (PRJNA407052), representing ST 18, 17, 78 and 192, respec-
tively, were used. They are hospital isolates either from the US or
Norway. Their properties and additional information are presented in
Table 1.
E. faecium strains were routinely cultured on brain heart infusion
(BHI) or Luria Bertani (LB) agar or in liquid BHI or LB at 37 °C.
2.2. Isolation of membrane vesicles
Vesicles were isolated as described for S. aureus [16, 21] with a few
modifications.
First, to isolate vesicles from bacteria mainly in a viable state, cul-
tures in mid-exponential growth phase grown in nutrient-rich BHI were
used (Fig. S1A). Therefore, 1 L of BHI broth were inoculated with en-
terococci grown overnight in BHI broth (1100) and grown at 37 °C with
shaking (230 rpm) to mid-exponential phase (optical density at 600 nm
[OD600], approximately 1.5). The cultures were centrifuged at 6000×g
for 30min with a JLA 9.1000 rotor Beckman Instruments Inc., USA) and
the supernatant was transferred to a clean Erlenmeyer flask and filtered
through a 0.22 μm pore size filter (Merck Millipore, USA). The obtained
bacterial-free filtrate was concentrated using Amicon tubes (Merck
Millipore, USA, cut off 100 kDa) in a “Beckman” centrifuge at 4000×g
for 30min at 4 °C and the concentrate was ultracentrifuged using a SW
40-TI rotor (20,000 x g for 3 h at 4 °C) to pellet MVs. The MVs were
washed in phosphate-buffered saline (PBS) followed by another ultra-
centrifugation, before re-suspention in PBS. Purified MVs were stored at
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to confirm the sterility of isolated MVs.
Second, in order to isolate vesicles from bacteria under stress,
bacterial stationary phase cultures grown in growth-limiting LB were
used (Fig. S1B). For this, the above-described procedure was applied to
enterococcal overnight cultures grown in LB.
2.3. Density gradient centrifugation (DGC)
DGC was performed in order to fractionate and purify the MVs
further. Therefore, the MV sample was mixed with an equal volume of
ice-cold 60% OptiPrep (Sigma-Aldrich, Germany; 60% stock) to obtain
a 30% solution. The 30% solution was transferred into the bottom of an
ultracentrifugation tube (ultraClear™, 5 mL, 13×51mm, Beckman
Instruments Inc., USA) and 2mL of 25% (w/v), 1 mL of 5% (w/v)
OptiPrep solution and PBS were added. Centrifugation was carried out
at 100000×g for 3 h at 4 °C (rotor SW 50.1, Beckman Instruments Inc.,
USA) in slow acceleration and deceleration mode to prevent dis-
turbance in the various density layers and achieve MV ring formation
(see example in Fig. S2A). After centrifugation, the sample was divided
into 200 μL fractions, which were transferred into clean Eppendorf
tubes. Aliquots of the fractions were analyzed by SDS PAGE (see ex-
ample in Fig. S2B) and electron microscopy.
To remove the OptiPrep solution, the fractions containing MVs were
pooled and concentrated by ultrafiltration (10 kDa molecular weight
cut-off, Vivaspin 20, Sartorius, Germany) at 4000×g for 30min at 4 °C
and re-suspended in 200 μL PBS.
2.4. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE)
Protein profiling of isolated MVs from all the four strains of en-
terococci was determined by SDS-PAGE using standard molecular stain.
Briefly, 15 μL of MV sample were mixed with 5.75 μL 4× NuPage LDS
sample buffer (NuPage Novex 4–12%; Invitrogen, Life Technologies,
USA) as well as 2.3 μL of dithiothreitol (DTT) and heated for 10min at
70 °C prior to electrophoresis. Samples were separated by 12% NuPage
Bis-Tris SDS-PAGE gel, and the gels were fixed in fixation solution
(methanol, acetic acid (50/50 v/v)) for 1 h at room temperature under
gentle agitation. The gels were then stained with Coomassie solution
(50% methanol, 10% acetic acid, 0.05% Coomassie brilliant blue R-250,
Thermo Fisher Scientific USA) for 1 h and excess dye was removed
through incubation in de-stain solution (H2O, methanol, acetic acid
(50/40/10v/v/v)) until bands were visible.
2.5. Transmission electron microscopy (TEM) analysis
Five μL of purified MVs were applied to Formvar coated 75 mesh
copper grids (Electron Microscopy Science, USA) and incubated for
5min. The sample was washed four times with double distilled water
and negatively stained with 9 parts of 2% methylcellulose and 1 part of
3% uranyl acetate for 2min on ice. The excess stain was removed and
samples were dried at room temperature. The samples were then vi-
sualized with a JEOL JEM 1010 transmission electron microscope
(JEOL, Japan) operated at 80 kV.
2.6. Atomic force microscopy (AFM) analysis
AFM analysis of E. faecium strains DO and E155 cultivated on LB
agar were performed as described previously [22]. A loop of bacterial
cells was suspended in ultrapure water and placed on a freshly cleaved
mica surface, incubated at room temperature and ultimately blotted dry
before being placed into a desiccator. Imaging was carried out using a
Nanoscope V Atomic Force Microscope (Bruker AXS, Germany).
2.7. Particle size distribution and measurement of zeta potential
The effective diameter and size distribution of the purified MVs
were determined by dynamic light scattering (DLS, also known as
photon correlation spectroscopy) (Nicomp Submicron Particle Sizer
370, PSS Nicomp Particle Sizing Systems, USA), at an angle of 90° with
a 632 nm laser as described in an earlier study [23]. Briefly, MVs were
diluted in PBS in a particle-free environment to a count rate of
250–350 kHz at room temperature. Analyses were run in a vesicle mode
data calculated as intensity weighted distribution from three measuring
cycles (10min cycle, 3 cycles) The zeta (ζ) potential of vesicles was
determined using Zetasizer Nano Z (Malvern Instruments, United
Kingdom). Three parallels were determined for each vesicle suspension.
2.8. Measurement of MV-derived protein per CFU
The protein content of isolated and purified MVs from bacterial
culture (2 L) was measured by Bradford assay (Bio Rad, USA). For each
strain, CFUs per mL were assessed by plating dilution series on blood
agar plates and counting CFUs. With these two values, MV-derived
protein in attogram (ag) per CFU was calculated from these two values.
2.9. Lipid staining of purified vesicles
The purified membrane vesicles were stained for 1 h with lipid-
specific dye (5 μM of DiD, Thermo Fisher Scientific, USA). The stained
vesicles were then ultra-centrifuged at a speed of 100,000× g for 1 h at
4 °C. The pellets were re-suspended in 20 μL PBS mounted on a glass
slide and examined using a confocal microscope (Leica Microsystems
CMS GmbH, Germany), with an excitation and emission spectra for DiD
at λ638nm and λ700nm, respectively.
2.10. Detection of peptidoglycan
ELISA was used to assess the presence of peptidoglycan, which was
exposed by incubating the membrane vesicles and bacteria with 25mM
HCl for 1 h at room temperature under shaking. Microtiter plates
(Maxisorb, Thermo Fischer Scientific, USA) were coated with mem-
brane vesicles or bacteria in coating buffer (100mM Sodium carbonate/
bicarbonate, pH 9.6) at 4 °C overnight. After 4 washes with PBS-T (PBS
with 0.01% Tween), plates were blocked with 0.05% BSA for 2 h at
37 °C and washed. To evaluate the presence of peptidoglycan in the
samples, mouse anti-bacterial peptidoglycan monoclonal antibody (IgG,
MAB995, Chemicon, Merck Millipore, USA; 1:1000) was added, and the
plate incubated for 2 h at 37 °C. Excess primary antibody was removed
by additional washing with PBS-T, before it was detected with perox-
idase-conjugated rabbit anti-mouse immunoglobulin (DAKO, Agilent,
USA; 1:500) for 20min at 37 °C. Thereafter, tetramethylbenzidine (3,
3′, 5, 5′-TMB, Sigma Aldrich, Germany) was added as peroxidase sub-
strate, and the reaction was stopped with sulfuric acid upon color
change. Absorption was measured at 450 nm.
2.11. MV-associated protein identification by mass spectrometry
The protein concentration within the MVs was quantified, and 20 μg
MV proteins were re-suspended in 8M urea. The sample was reduced by
adding 20mM DTT and alkylated with 40mM iodoacetamide.
Alkylation was quenched by 10mM DTT. Proteins were digested 4 h by
1:100 (w/w) lysyl endopeptidase (Wako Biochemicals, USA). The
sample was diluted to 1M urea and digested overnight by 1/20 (w/w)
trypsin (V511A, Promega, USA). OMIX C18 tips (Varian Inc., USA) were
used for sample cleanup and concentration. Peptide mixtures con-
taining 0.1% formic acid were loaded onto an EASY-nLC1000 system
(Thermo Fisher Scientific, USA) and EASY-Spray column (C18, 2 μm,
100 Å, 50 μm, 50 cm). Peptides were fractionated using a 2–100%
acetonitrile gradient in 0.1% formic acid over 50min at a flow rate of
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250 nL/min. The separated peptides were analyzed using a Q-Exactive
mass spectrometer (Thermo Fisher Scientific, USA). Data were collected
in data-dependent mode using a Top10 method. The raw data were
processed using the Proteome Discoverer 2.1 software. The fragmen-
tation spectra were searched against the predicted proteome from the
whole genome sequence (WGS) data of the strain itself using the
Sequest HT program. Peptide mass tolerances used in the search were
10 ppm, and fragment mass tolerance was 0.02 Da. Peptide ions were
filtered using a false discovery rate (FDR) set to 5% for protein iden-
tifications.
The MV-associated proteins were identified in 3 biological replicates
of MV derived from bacteria in the exponential growth phase in BHI,
and are represented as one in the results table without restrictions
(Supplementary table S1). For MV derived from bacteria in the sta-
tionary growth phase in LB one biological replicate is described in the
result table (Supplementary table S1).
2.12. Bioinformatic characterization of identified MV proteins
To evaluate MV-associated proteins, the entire proteomes were
classified into core and strain(s)-specific. The core proteome was as-
signed with the proteins shared by all four strains whereas the strain(s)-
specific proteome had proteins found only in one or few strains. All
proteins were clustered using CD-HIT with default settings [24].
Homologous clusters possessing at least one protein from each strain
were categorized into core proteins, if not as strain(s)-specific proteins.
Overlapping protein content among MVs isolated from four dif-
ferent strains was demonstrated using Venny 2.0 [25]. These results
were shown individually for proteomes of MVs isolated after growth in
LB to stationary phase and in BHI to mid-exponential phase.
Prediction of signal peptide cleavage sites was performed in SignalP
4.1 [26] and PrediSi [27] on all proteins identified in the MV pro-
teomes. The subcellular localization of identified proteins was predicted
using PSORTb version 3.0 [28]. Gene-term enrichment analysis was
performed with DAVID Functional Annotation Tool [29] on proteins
with an exponentially modified protein abundance index (empai) above
1.
Selected virulence factors and vaccine candidates were searched for
using BLAST [30].
Antimicrobial resistance genes were identified within the respective
genomes of the bacterial strains using ResFinder 3.0 [31] with an ID
threshold of 90% and a minimum length of 60%. Genes with<100%
ID threshold and 100% minimum length are indicated in Table 2.
Identified genes are aph(3′)-III, aac(6′)-aph(2″); vanR-A, vanS-A, vanH-
A, van-A, vanX-A, vanY-A, vanZ-A, vanR-B, vanS-B, vanY-B, vanW-B,
vanH-B, vanB, vanX-B; ermB, lnuB, msrC, tetM and dfrG. The corre-
sponding proteins were searched for in the MV proteome in order to
identify MV-associated antimicrobial resistance determinants.
3. Results
3.1. Clinical E. faecium strains produce MVs
This study explored whether four different clinical E. faecium
strains, belonging to distinct hospital adapted high-risk STs, were able
to release membrane vesicles in vitro. Notably, the growth rates of the
examined strains at the measured intervals showed only minor varia-
tion (Fig. S1).
MVs were isolated from E. faecium strains, which were grown in BHI
until mid-exponential phase (OD600 approximately 1.5). To ensure
purity of the vesicles from cellular debris and protein aggregates, MVs
were further purified and fractionated by gradient centrifugation (Fig.
S2A). The purified MVs were analyzed by TEM where the presence of
vesicle-like circular shape structures was confirmed (Fig. 1A). Similar
structures were detected for the other three examined strains (results
not shown). AFM was conducted as a complementary approach and
revealed release of MVs by the bacteria to the surrounding environment
(Fig. 1B). To measure the size distribution of larger populations of MVs
from the four E. faecium strains, dynamic light scattering (DLS) was
employed. While all strains generated MVs of various sizes, the average
size of enterococcal MVs ranged from 37 ± 23 nm in the E155 strain to
83 ± 29 nm in the K59–68 strain (Fig. 1C and Table 1). Furthermore,
the size measured by DLS corresponded to the results obtained from
TEM images (Fig. 1A–C, Table 1).
Based on protein content, the amount of MVs produced by the four
strains ranged from 1.2 ag/CFU in strain K59-68 to 14.6 ag/CFU in
strain E155 (Fig. 1D).
To gain insight into the interaction of the MVs in the colloidal
system and gain a better understanding of their physiochemical prop-
erties (aggregation, flocculation or dispersion), the membrane (ζ-) po-
tential, of the MVs was measured. The ζ-potential was calculated upon
measuring particles electrophoretic mobility. The E. faecium MV surface
charge in all examined strains was found to be negative in PBS and
reproducible (Table 1) demonstrating a high quality of the MV isola-
tion.
To further characterize the vesicle properties, the purified MVs of
strain E155 were stained with a lipophilic fluorescent dye (DiD) for
detection of lipids. The confocal microscopy analysis of the stained MVs
confirmed the presence of lipids in MVs (Fig. 2A). The presence of
peptidoglycan in the isolated MVs from all four strains was evaluated
using a competitive ELISA approach. Interestingly, peptidoglycan could
be detected in E. faecium-derived MVs from all examined strains. E.
faecium cells were included as a positive peptidoglycan control for this
particular assay (Fig. 2B).
3.2. Different cultural conditions and strain backgrounds account for
variation in enterococcal MV proteinaceous cargo
To investigate whether the MV protein cargo is strain dependent
and influenced by different conditions, the four strains were grown to
exponential phase in a nutritious media, BHI, and to stationary phase in
a growth-limiting media, LB. MVs were isolated and purified further by
gradient centrifugation, and proteomic analysis was performed using an
in-solution approach.
Proteomic analyses demonstrated variability in the number of
identified proteins among MV-associated proteins isolated from the four
selected strains grown in BHI and LB (Supplementary Tables 1–8).
Comparison of shared versus unique proteins revealed that, in ex-
ponential growth in BHI, a lower number (19.2%) of MV-associated
proteins was shared than in stationary growth in LB (36.9%), as illu-
strated in Fig. 3. MVs from K60-39 showed the highest number of total
MV-associated proteins and consequently also possess most unique MV-
associated proteins under both conditions. In contrast, MVs from K59-
68 showed a lower number of total vesicle associated proteins and
accordingly the lowest number of unique proteins.
Based on the sequence similarity of the entire proteome encoded by
all four genomes, homologous proteins present in all four were classi-
fied as core and the remaining as accessory. Accordingly, the MV-as-
sociated proteins were categorized based on their occurrence either in
core or accessory proteome. Notably, it was found that 88–91% of the
MV-associated proteins are from the core proteome (Table 1).
The predicted cellular localization of proteins encoded by the whole
genome based on WGS data and the origin of MV-associated proteins
was predicted by PSORTb. The predicted localization of proteins
showed a common pattern among strains and MV-associated proteins
originating from two different conditions (Fig. 4). As expected, most of
the MV-associated proteins were predicted as either cytoplasmic or part
of the cytoplasmic membrane proteins. A minor number of cell wall or
extracellular bound proteins were also predicted in the derived MVs.
SignalP and PrediSi were applied to predict the presence of signal
peptides. Although the number of identified proteins varied sub-
stantially between strains and conditions, the percentage of putative
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secreted proteins was comparable (Fig. 5). In all strains 4–5% of the
ORFs encode secreted proteins in the whole genome proteomes, while
10–22% secreted proteins were predicted in MVs derived from ex-
ponential growth phase in BHI, and 5–12% secreted proteins in MVs
derived from stationary growth phase in LB. The highest number of
secreted (22%) and extracellular (4%) proteins was associated with MV
proteinaceous cargo obtained from K59–68 grown in BHI to the mid-
exponential phase.
Gene functional enrichment analyses for strain DO identified 10
functional annotation clusters in MV-associated proteins from ex-
ponential growth conditions in BHI and 16 functional annotation
clusters in MV-associated proteins from stationary growth phase in LB.
The difference in cluster number is probably due to the lower protein
number in exponential growth phase (for empai> 1 nprotein= 138)
compared to stationary growth phase (for empai> 1 nprotein= 258).
The analysis showed that ribosomal, ATP synthesis, and membrane
proteins were enriched in both exponential and stationary growth
phase derived MVs in DO. The gene ontology enrichment analysis is
illustrated in Fig. 6.
3.3. Presence of virulence factors, vaccine candidates, and antimicrobial
resistance-related proteins among the E. faecium MV-associated proteins
Fifteen distinct E. faecium genes encoding virulence factors, asso-
ciated with biofilm formation and adherence, were identified within the
genomes of the 4 examined strains: atlA [32], acm [33, 34], bepA [35],
capD [36], ccpA [37, 38], ecbA [39], esp [40], fnm [41], pilA2 [42], pilB/
ebpfm [43], ptsD [44], prpA [45], sagA [46–48], scm [49] and sgrA [39].
gelE [50] was also searched for but was absent in the selected genomes.
Presence or absence of selected virulence factors associated with the
E. faecium-derived MVs is indicated in Table 2. Proteomic analysis de-
monstrated the absence of BepA, EcbA, PilB/Ebpfm and SgrA in the
purified MVs. Interestingly, the two biofilm determinants, namely AtlA
and SagA, were found to be associated with MVs of all tested strains
under both conditions. The adhesins Acm and CapD as well as the
catabolite protein CcpA were also associated with purified MVs of all
examined strains. Esp, an enterococcal surface protein enhancing bio-
film formation, Fnm, a fibronectin-binding protein, PilA2, a pilus pro-
tein, PrpA, an extracellular matrix binding protein, PtsD, a phospho-
transferase system protein, and the adhesin Scm, were associated with
MVs from some of the examined strains.
The search was expanded to further include the enterococcal bac-
teriocins EntA, EntP, EntB, EntL50 [51], EntQ [52], Bac32 [53] and
Table 2
Presence of virulence factors and antibiotic resistance related proteins associated with MVs.
Virulence factor and functional description WGS MV
Tag in genome stationary phase MV (LB) exponential phase MV (BHI)
DO E155 K60–-39 K59–-68 DO E155 K60–-39 K59–-68 DO E155 K60–-39 K59–-68
AtlA Major autolysin, biofilm formation Q3Y3J6 E155_00939 7_02408 6_02630 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Acm Collagen binding adhesion,
MSCRAMM
Q3XXN7 E155_00761 7_02160 6_02383 ✓ ✓ ✓ ✓ X X X ✓
CapD Capsular polysaccharide biosynthesis
protein, adhesion
Q3XXA5 E155_00870 7_00899 6_00915 ✓ ✓ ✓ X ✓ ✓ ✓ ✓
CcpA Catabolite control protein A, growth,
virulence
I3U3N8 E155_00210 7_01900 6_02068 ✓ ✓ ✓ X ✓ ✓ ✓ ✓
Esp Enterococcal surface protein, biofilm
formation
- - - 6_02803 - - - ✓ - - - -
Fnm Fibronectin binding protein, adhesion Q3XYE6 E155_00278 7_01343 6_01354 X ✓ ✓ X ✓ ✓ ✓ X
PilA2 Pilus subunit protein A Q3Y0Y4 - 7_02894 6_03276 X - ✓ X ✓ - X X
PrpA Prolinrich protein A, binding to
extracellular matrix proteins
Q3XZP6 - 7_01420 6_01433 ✓ - X X ✓ - X X
PtsD Enzyme IID subunit of
phosphotransferase stystem, intestinal
colonization determinant
Q3Y1Z0 E155_00486 7_00634 6_00710 X X X X ✓ ✓ X X
SagA Secreted antigen A, biofilm formation I3U595 E155_00236 7_02462 6_02688 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Scm Collagen adhesion, MSCRAMM I3U5K9 - 7_02636 6_02858 ✓ - X ✓ ✓ - X ✓
Vaccine candidate
PsaA Metal binding lipoprotein Q3Y2A0 E155_02566 7_00432 6_00512 ✓ ✓ ✓ ✓ ✓ ✓ ✓ X
PBP5 Penicillin binding protein Q3XZN6 E155_02659 7_01431 6_01444 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
LysM Peptidoglycan binding protein Q3Y2A3 E155_01532 7_00435 6_00515 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
DdcP D,D-carboxypeptidase I3U3E0 E155_02369 7_01824 6_01978 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
PpiC Peptidyl-prolyl-cis-trans-isomerase Q3Y2Y5 E155_01118 7_02348 6_02568 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓




Aminoglycoside resistance - E155_02844 - 6_03206 - X - ✓ - ✓ - X
Aph3′-III Aminoglycoside resistance Q3Y248 E155_02752 7_03002 6_03355 ✓ ✓ X ✓ ✓ ✓ X X
VanR-A Glycopeptide resistance - E155_02402 - - - ✓ - - - - - -
VanS-A Glycopeptide resistance - E155_02403 - - - ✓ - - - - - -
VanH-A Glycopeptide resistance - E155_02496 - - - ✓ - - - - - -
VanA Glycopeptide reistance - E155_02495 - - - ✓ - - - ✓ - -
VanX-A Glycopeptide resistance - E155_02494 - - - ✓ - - - - - -
VanY-A Glycopeptide resistance - E155_02850 - - - ✓ - - - ✓ - -
VanZ-A Glycopeptide resistance - E155_02851 - - - ✓ - - - ✓ - -
VanS-B Glycopeptide resistance - E155_02765 (ID:
96.49%)
- - - ✓ - - - - - -
ErmB Macrolide resistance Q3Y241 E155_02538 7_03003 6_03356 X ✓ ✓ X X X X X
MSCRAMM - Microbial Surface Component Recognizing Adhesive Matrix Molecules, ✓ presence, X absence, - not within genome.
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Bac43 [54]. Out of those, only the gene entA was present in all the four
genomes used in this study, but EntA was not found to be associated
with the E. faecium derived MVs.
As previous studies have identified putative enterococcal vaccine
targets, the following candidates were searched for in the vesicular
proteome: PsaA, AdcA [55], PBP5, LysM, DdcP, PpiC [56] and SagA
[48] (Table 2). PsaA and AdcA are both metal binding lipoproteins
[55], and PsaA was found associated with MVs from all four strains.
PBP5, LysM, DdcP, and PpiC are putative surface-exposed proteins,
which are associated with peptidoglycan [56], and all four were found
within all the examined MV samples. Additionally, SagA, which was
present in all MV samples, was not only described as a virulence factor
[46, 47], but also as the first promising vaccine candidate in E. faecium,
as it exhibited protective properties in a mouse model [48].
Furthermore, resistance genes were identified in the four genomes
using ResFinder [31], and subsequently, the corresponding proteins
were searched for in the MV proteomes (Table 2). The protein Aph3′-III,
a kanamycin kinase conveying resistance to aminoglycosides, was
found in MV samples in both conditions. Aac6′-Ie-Aph2″-Ia, a
bifunctional protein conferring broad-spectrum resistance to ami-
noglycosides such as gentamicin through N- and O-acetylation and
phosphorylation of hydroxyl groups [57], was associated with DO-,
E155- and K59-68-derived MVs, isolated from BHI and/or LB cultures.
ErmB, conferring macrolide, such as erythromycin, resistance, was as-
sociated with E155- and K60-39-derived MVs grown in LB to the sta-
tionary phase.
All proteins encoded by the vanA-cluster that contribute to glyco-
peptide resistance [58] were associated with E155-derived MVs grown
in LB to the stationary growth phase: VanR-A, VanS-A, VanH-A, VanA,
VanX-A, VanY-A, VanZ-A. A subset of those was also present in MVs
isolated from exponential growth phase. Additionally, VanS-B encoded
by the vanB-cluster was found associated with E155-derived MVs grown
to the stationary growth phase. However, the E155 genome also en-
codes the rest of the genes of the vanB-cluster: vanR-B, vanY-B, vanW-B,
vanH-B, vanB and vanX-B, but they were absent in the MVs (Table 2).
The macrolide resistance genes lnuB (K60-39) and msrC (all 4
strains) were present in the respective genomes but absent in the MVs.
This also accounts for tetM (DO and K59-68) and dfrG (E155).
Fig. 1. E. faecium releases spherical MVs in vitro. A)
TEM of MVs isolated from E. faecium E155 (the inset
in the upper left corner shows the vesicle indicated
by an arrow 2 times magnified). B) AFM of E. faecium
E155 surrounded by MVs (the inset in the upper left
corner shows the vesicle indicated by an arrow 2
times magnified). C) Abundance of the various sizes
of purified MV from DO, E155, K59-68 and K60-39
grown to exponential phase in BHI as determined by
DLS (mean in nm ± SD). D) MV-derived protein per
CFU in DO, E155, K59-68 and K60-39 in cultures
grown in BHI to OD600 approximately 1.5.
Fig. 2. E. faecium MVs contain lipids and pepti-
doglycan. A) Confocal microscopy of MVs stained
with lipid-tracer dye (DiD shown in red, the inset in
the upper left corner shows the vesicle indicated by
an arrow 2 times magnified). B) Fold changes in
absorbance using anti-peptidoglycan antibodies in
ELISA to detect peptidoglycan in bacteria and MVs
isolated for the four strains at mid-exponential
growth phase in BHI compared to the control (un-
coated well). (For interpretation of the references to
color in this figure legend, the reader is referred to
the web version of this article.)
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4. Discussion
All cells investigated so far have been found to release vesicles,
indicating a universal phenomenon. The release of bacterial membrane
vesicles and their functional importance, including both offense and
defense, has been widely studied in Gram-negative bacteria [59]. In
recent years, vesicle research has also increased in Gram-positive bac-
teria such as Listeria [60], Bacillus [16], Staphylococcus [61], Lactoba-
cillus [62], Streptococcus [63] and Clostridium [64]. Here we provide the
first report describing MVs released by E. faecium.
Rivera et al. [16] observed spherically shaped vesicles with the size
of 50–300 nm in B. anthracis. Similarly, MV isolated from Listeria, Sta-
phylococcus, Lactobacillus, Streptococcus, and Clostridium ranged from 20
to 400 nm [60, 61, 63, 65]. The morphology of MVs secreted by E.
faecium was found to be similar to the above-mentioned MVs from
Gram-positive bacteria, both in terms of size and appearance (Fig. 1,
Table 1). We also quantified the vesicles based on protein measurement
through Bradford reagent and found similar MV amounts produced by
the four E. faecium strains. However, a drawback of these types of
measurement approaches is the lack of a universal standard procedure
for MV quantification. Until now, vesicular proteins have been quan-
tified using protein-based (SDS-PAGE staining, Bradford reagent or bi-
cinchoninic-acid assay BCA) and lipid-based (lipid probes such as
FM4–64) approaches. However, all these methods have both strengths
and weaknesses [66]. Moreover, for the proteomic analysis assessment
of the purity of the MV sample is utmost important. Contaminating
artifacts may co-pellet in the ultracentrifugation step of MV isolation.
However, density gradient centrifugation was included in our study,
which improves the purity of the MV sample [66, 67].
As previously described in Gram-negative bacteria [68] and the
Gram-positive bacterium Clostridium perfringens [64], peptidoglycan
was confirmed to be associated with enterococcal vesicles, through use
of an antibody with specificity for the three-dimensional polymer
complex structure of peptidoglycan. In addition, the MVs from all four
strains exhibited negative surface charge, based on ζ-potential. The
surface charge of Pseudomonas aeruginosa and B. anthracis derived MVs
was also reported to be negative [16, 69] and in P. aeruginosa the ζ-
potential was more negative in stationary growth phase derived vesicles
compared to exponential growth phase [69]. Gram-positive and Gram-
negative bacterial cells are negatively charged, too. It has been sug-
gested that the charge is critical to understand the interaction between
MVs and the bacterial cells [69] and the selectivity of this interaction
since it was found that MVs are more likely to interact with bacterial
cells of the parent species than of other genera [70].
Besides the morphological characterization, a mass spectrometry
based approach was used to gain insight into the proteomic profile of
the isolated MVs. The overall proteomic pattern within MVs was similar
regarding the percentage of proteins that derived from the core
genome, their origin of localization, and whether they had a signal
peptide or not (Figs. 3–5). However, different numbers of MV-asso-
ciated proteins identified by proteomics were found among the four
examined strains and under varying conditions (Table 1, Fig. 3). Among
Gram-positive bacteria substantially varying numbers of MV-associated
proteins have been described previously, from 431 MV-associated
proteins in C. perfringens grown in Trypticase-peptone-glucose broth
[65] to 36 MV-associated proteins in B. anthracis 34F2 in BHI [16]. The
growth medium affects the gene expression in bacteria which subse-
quently alters the amount and/or content of vesicles released into the
Fig. 3. Four-set Venn diagram representing the number of shared and unique MV-associated proteins of MVs isolated from E. faecium cultures. A) Mid-exponential
phase growth in BHI, B) Stationary phase growth in LB. Numbers of shared or unique proteins are given in bold, percentage in brackets.
Fig. 4. Localization prediction of proteins in whole genome proteomes and in
proteomes of MVs derived from two different conditions. Subcellular localiza-
tion prediction was done in PsortB and is illustrated in proportional numbers.
Fig. 5. Proportion of proteins with a signal peptide in E. faecium whole genome
proteomes and MV associated proteomes from two different conditions. Signal
peptide prediction was done by SignalP.
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growth medium [71]. Similarly, Bager et al. found significant changes
in OMV production and protein composition upon altering medium
composition in Gallibacterium anatis [72]. Moreover, a recent study on
the proteome of Pseudomonas putida KT2440 by Choi et al. demon-
strated that OMV production in LB media was three-fold higher than in
two different minimal media containing succinate and benzoate [73].
Other previous studies identified a higher number of vesicular proteins
in P. aeruginosa in LB compared to a more nutrient rich media [74–76].
Likewise, in our study, we observed a higher number of different pro-
teins in MVs derived from E. faecium grown to stationary growth phase
in nutrient-limiting LB compared to exponential growth in nutrient rich
BHI. Under nutrient limitation and stationary growth, we expect the
bacteria suffer more stress, which might explain more different vesi-
cular proteins.
In the presented study we found a high abundance of cytoplasmic
proteins, especially ribosomal proteins, which is similar to the number
of cytoplasmic proteins encoded by the genome (Figs. 4, 6). This is in
agreement with previous studies of MVs derived from Gram-positive
bacteria [15, 19, 61]. This implicates, that the MV content represents
basically the composition of the parent cell, even though final conclu-
sions would require protein quantification rather than identification.
We furthermore found, that high numbers of MV-associated proteins
lack a secretion signal, which is in line with a previous study on S.
aureus [21] as well as Campylobacter jejuni [77] and suggests that MVs
may play an important role in the delivery of effector molecules, which
lack a secretion signal.
As previous studies have shown that MVs of Gram-positive bacteria
contain virulence factors [15, 16, 60, 78], serve as vaccine candidates
[79] and are contributing to antimicrobial resistance [80], in silico
methods were used to assess whether such factors are also associated
with E. faecium MVs. Indeed, we identified 11 known virulence factors
among the MV-associated proteins, including adhesins (CapD and
PrpA), collagen-binding proteins (Acm and Scm), and fibronectin-
binding protein (Fnm). These virulence factors are of particular im-
portance for enterococcal adhesion, colonization and tissue invasion
[34, 36, 41, 45, 49]. The association of collagen-binding proteins, as
well as the fibronectin-binding protein and adhesins with MVs may
suggest a role of the vesicles in enterococcal adhesion and colonization.
E. faecium utilizes biofilm formation as a survival strategy, which
enables protection and persistence [81, 82]. Previous studies demon-
strated that OMVs contribute to biofilm formation and stability [83,
84]. The virulence factors AtlA, Esp and SagA that contribute to en-
terococcal biofilm formation [32, 40, 46–48] were found to be MV-
associated. This may suggest that E. faecium MVs can contribute to
biofilm formation.
As highly stable, non-infectious, non-replicative particles vesicles
are interesting vaccine candidates. Furthermore, they contain major
immunogenic proteins of the MV producing bacterium that can act as
antigens and thus can elicit responses in both arms of the immune
system. Additionally, they display adjuvant activity (reviewed in [79,
85]). The first OMV-based vaccine to be licensed for human use was the
meningococcal serogroup B vaccine 4CMenB against the Gram-negative
Neisseria meningitidis [86]. Also in the Gram-positive Streptococcus
pneumoniae [87] and S. aureus [21, 88], the protective effect of im-
munization with MVs was recently shown. For enterococci, there are to
date no available vaccines, but there has been research towards iden-
tifying components for a vaccine to prevent E. faecium infection [48, 55,
56]. Here we found several previously described vaccine candidates to
be associated with MVs (Table 2). However, whether enterococcal MVs
can be used as vaccines remains to be investigated.
Special interest has been drawn to E. faecium due to their multidrug
resistance and high genomic plasticity, which allows them to steadily ac-
quire new resistance determinants. In the Gram-negative E. coli it was
shown that OMVs not only have a protective role against membrane-active
antimicrobials [80], but also that certain antimicrobials increase the pro-
duction of OMVs and OMV-associated Shiga toxin [89, 90]. Also resistance-
genes were found to be transferred via OMVs [91]. Furthermore, OMVs of
β-lactamase resistant Haemophilus influenzae and Moraxella catarrhalis were
shown to protect Streptococcus pyogenes against amoxicillin [92]. Interest-
ingly, our study demonstrates that both the ribosome methylase ErmB, the
aminoglycoside modifying enzymes Aac6′-Ie-Aph2″-Ia and Aph3′-III as well
as all proteins of the vanA vancomycin resistance cluster can be MV-asso-
ciated in E. faecium. All these proteins mainly function inside the en-
terococcal cell. Thus they could potentially be active in creating anti-
microbial resistance if they can be delivered to a recipient cell by the MVs.
However, low empai values of the vanA-cluster encoded proteins, ErmB,
Aac6′-Ie-Aph2″-Ia and Aph3′-III under the conditions studied here, suggest
that these MVs do not have a great potential to cause antimicrobial re-
sistance. Still, MV production and thus resistance-conferring proteins could
be more abundant upon induction through antimicrobial stress as seen in
MVs from Stenotrophomonas maltophilia [93] and E. coli [89] and then be
presented in high enough concentrations to a recipient cell to confer an
antimicrobial effect. This implicates that enterococcal MVs may play a role
in antimicrobial resistance, not only for E. faecium itself but also for the
bacterial community.
The mechanism of vesiculogenesis has not been conclusively clar-
ified in Gram-positive bacteria. Recently, prophage-triggered MV for-
mation was described and it has been postulated that phage endolysins
may confer MV escape by locally digesting the cell wall [94]. Inter-
estingly, by using PHASTER tool [95], we detected phage genes within
the genomes of DO, K59–68 and K60-39, but not in E155 (results not
shown). Thus, prophages may play a role in the release of MV from
certain strains. Apart from prophage-triggered MV formation, it has
been suggested, that the vesicles passage the peptidoglycan layer with
the aid of cell wall modifying enzymes such as peptidoglycan mur-
amidases/ hydrolases, which are part of the Gram-positive type 4 se-
cretion system (T4SS) [6, 15]. In the genomes of the four strains, we
found T4SS using T346Hunter [96] (data not shown), suggesting that
these strains might use components of this system for vesicle release.
However, the mechanism for MV release in enterococci remains elusive.
Fig. 6. Distribution of DO MV-associated proteins from two different conditions compared to the whole genome proteome of DO in gene ontology enrichment
analysis. Proteome of MVs derived in exponential growth in BHI is shown in A) and stationary growth in LB in B).
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5. Conclusion
A proteomic approach was used to describe the protein cargo of
membrane vesicles derived from four different, clinically relevant E.
faecium strains under varying conditions. It was found that the MV-
associated proteome is strain and condition dependent. The most in-
teresting MV-associated proteins were the virulence factors and anti-
microbial resistance related proteins. It is thus tempting to speculate
that enterococcal MVs play an important role in infection and anti-
microbial resistance. Our findings highlight the potential of bacterial
MVs for research on bacterial pathogenesis.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.jprot.2018.05.017.
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